Potent inhibitors of the MAP kinase p38

Potent inhibitors of the MAP kinase p38 A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis Discovery of a new class of p38 kinase inhibitors p38 Kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas Synthesis and pharmacological characterization of a potent, orally active p38 kinase inhibitor The design and synthesis of novel α-ketoamide-based p38 MAP kinase inhibitors The development of new bicyclic pyrazole-based cytokine synthesis inhibitors Design, Synthesis, and Biological Evaluation of Phenylamino-Substituted 6,11-Dihydro-dibenzo[b,e]oxepin-11-ones and Dibenzo[a,d]cycloheptan-5-ones:  Novel p38 MAP Kinase Inhibitors Docking, synthesis and pharmacological activity of novel urea-derivatives designed as p38 MAPK inhibitors Targeting the Hinge Glycine Flip and the Activation Loop: Novel Approach to Potent p38α Inhibitors